[go: up one dir, main page]

TW200731970A - Enhanced efficacy benzisoxazole derivative dosage forms and methods - Google Patents

Enhanced efficacy benzisoxazole derivative dosage forms and methods

Info

Publication number
TW200731970A
TW200731970A TW095138307A TW95138307A TW200731970A TW 200731970 A TW200731970 A TW 200731970A TW 095138307 A TW095138307 A TW 095138307A TW 95138307 A TW95138307 A TW 95138307A TW 200731970 A TW200731970 A TW 200731970A
Authority
TW
Taiwan
Prior art keywords
methods
dosage forms
enhanced efficacy
benzisoxazole derivative
derivative dosage
Prior art date
Application number
TW095138307A
Other languages
English (en)
Inventor
Michelle Kramer
Peter Briscoe
Sandra Boom
An Vermeulen
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38734884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200731970(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/262,113 external-priority patent/US20060189635A1/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of TW200731970A publication Critical patent/TW200731970A/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW095138307A 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods TW200731970A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72862005P 2005-10-19 2005-10-19
US11/262,113 US20060189635A1 (en) 2005-02-04 2005-10-27 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Publications (1)

Publication Number Publication Date
TW200731970A true TW200731970A (en) 2007-09-01

Family

ID=38734884

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138307A TW200731970A (en) 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Country Status (5)

Country Link
AR (1) AR057161A1 (zh)
GT (1) GT200600467A (zh)
PE (1) PE20071028A1 (zh)
TW (1) TW200731970A (zh)
UY (1) UY29877A1 (zh)

Also Published As

Publication number Publication date
AR057161A1 (es) 2007-11-21
UY29877A1 (es) 2006-12-29
GT200600467A (es) 2007-09-21
PE20071028A1 (es) 2007-11-30

Similar Documents

Publication Publication Date Title
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
MY165570A (en) Inhibitors of poly (adp-ribose) polymerase
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
EP2192901A4 (en) CHEMICAL AGENTS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND RELATED DISEASES
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2010002667A (es) Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2005000192A3 (en) Glycogen synthase kinase-3 inhibitors
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
WO2007047608A3 (en) Fibrin targeted therapeutics
WO2007130501A3 (en) Combination therapy for treatment of cancer
TW200716088A (en) Formulations and methods for treating amyloidosis
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
MXPA05010388A (es) Dispositivos, metodos y composiciones para prevenir la restenosis.
MXPA05013121A (es) Derivados de indol con efecto de induccion de apoptosis.
TW200716561A (en) P38 inhibitors and methods of use thereof